Outsourcing

Pharmaceutical Outsourcing Present and Future

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Navigating the Preclinical CRO Outsourcing Process

The need for preclinical testing expertise is growing as molecular complexity increases.

A Closer Look at Affinity Ligands

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

Polysorbates: Part(icle) of the Problem?

May 05, 2024

A comparison between polysorbates and HPβCD determines the better stabilizer for biologics formulation.

Cormica Announces Seven-Figure Acquisition of TPM Laboratories

May 03, 2024

Cormica’s first US Acquisition is intended to support to organic growth of TPM laboratories.

CPHI Experts Report that Small to Mid-sized US CDMOs Must Invest Now to Benefit from 2025 Contract Funding Surge

April 30, 2024

Key areas to invest include manufacturing process improvements, quality management, and AI.

SK pharmteco to Ensure Supply of Ferring Pharmaceuticals Gene Therapy

April 27, 2024

SK pharmteco, a CDMO, will manufacture, test, and release Adstiladrin (nadofaragene firadenovec-vncg), a gene therapy from Ferring Pharmaceuticals for treating bladder cancer.

How New Regulations Are Impacting Pharmaceutical Manufacturing Facility Design

April 19, 2024

New regulations, including those put forth by Annex 1, require many pharmaceutical manufacturers to rethink their facility designs to promote compliance.

Annex 1 Alignment: Addressing Contamination Control and Assessing Risk

April 17, 2024

At INTERPHEX 2024, Pharmaceutical Technology sat down with Christa Myers of CRB Group and Nadiyra Walker Speight of Fujifilm Diosynth Biotechnologies to discuss implementation of Annex 1.

Lonza Forms Agreement to Manufacture Acumen Pharmaceuticals’ AD mAb Therapy

April 05, 2024

Under a collaboration agreement, Lonza will manufacture sabirnetug, Acumen Pharmaceuticals' mAb in clinical development for treating Alzheimer’s disease.

Taking Full Advantage of Service Providers

April 02, 2024

There are considerations companies may want to consider before seeking out a service provider.

White Raven to Increase Manufacturing Efficiency with Cytiva’s Aseptic Filling Workcell

March 22, 2024

CDMO White Raven aims to reduce contamination risk and gain the capability to handle multiple product formats with the installation of Cytiva’s SA25 Aseptic Filling Workcell.

FDA Greenlights Orchard Therapeutics' Gene Therapy for Children's MLD; AGC Biologics Selected for Manufacturing

March 20, 2024

FDA's approval makes Orchard Therapeutics' Lenmeldy (atidarsagene autotemcel) the first gene therapy approved to treat pediatric metachromatic leukodystrophy in the US.